Drägerwerk AG & Co. KGaA Stock Forecast, Price & News

+0.80 (+1.08 %)
(As of 04/19/2021 12:00 AM ET)
Today's Range
Now: €74.95
50-Day Range
MA: €68.22
52-Week Range
Now: €74.95
Volume77,517 shs
Average Volume33,804 shs
Market Capitalization$644.57 million
P/E Ratio7.33
Dividend Yield0.26%
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Drägerwerk AG & Co. KGaA logo

Industry, Sector and Symbol

Industry Medical Devices
Year FoundedN/A



Sales & Book Value

Annual Sales$3.41 billion
Cash Flow€34.71 per share
Book Value€55.06 per share



Market Cap$644.57 million
Next Earnings DateN/A
OptionableNot Optionable


DAX Rises In Cautious Trade
April 15, 2021 |
DAX Tumbles As Virus Worries Deepen
October 15, 2020 |
August 19, 2020 |
See More Headlines


Overall MarketRank

1.45 out of 5 stars

Analyst Opinion: 3.3Community Rank: 1.9Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
+0.80 (+1.08 %)
(As of 04/19/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DRW3 News and Ratings via Email

Sign-up to receive the latest news and ratings for DRW3 and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Drägerwerk AG & Co. KGaA (ETR:DRW3) Frequently Asked Questions

Is Drägerwerk AG & Co. KGaA a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Drägerwerk AG & Co. KGaA in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Drägerwerk AG & Co. KGaA stock.
View analyst ratings for Drägerwerk AG & Co. KGaA
or view top-rated stocks.

What stocks does MarketBeat like better than Drägerwerk AG & Co. KGaA?

Wall Street analysts have given Drägerwerk AG & Co. KGaA a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Drägerwerk AG & Co. KGaA wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Drägerwerk AG & Co. KGaA's stock price been impacted by COVID-19?

Drägerwerk AG & Co. KGaA's stock was trading at €52.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, DRW3 shares have increased by 43.9% and is now trading at €74.95.
View which stocks have been most impacted by COVID-19

Is Drägerwerk AG & Co. KGaA a good dividend stock?

Drägerwerk AG & Co. KGaA pays an annual dividend of €0.19 per share and currently has a dividend yield of 0.26%. The dividend payout ratio of Drägerwerk AG & Co. KGaA is 1.86%. This payout ratio is at a healthy, sustainable level, below 75%.
View Drägerwerk AG & Co. KGaA's dividend history.

What price target have analysts set for DRW3?

6 equities research analysts have issued twelve-month price objectives for Drägerwerk AG & Co. KGaA's stock. Their forecasts range from €71.00 to €95.00. On average, they anticipate Drägerwerk AG & Co. KGaA's stock price to reach €82.60 in the next year. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for Drägerwerk AG & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are Drägerwerk AG & Co. KGaA's key executives?

Drägerwerk AG & Co. KGaA's management team includes the following people:
  • Mr. Stefan A. Dräger B.A., Chairman of the Exec. Board - Drägerwerk Verwaltungs AG (Age 58, Pay $2.16M)
  • Mr. Gert-Hartwig Lescow, CFO, Exec. Board Member for IT & Vice Chairman of Exec. Board - Drägerwerk Verwaltungs AG (Age 54, Pay $1.41M)
  • Mr. Anton Schrofner, Exec. Board Member for Medical Division - Drägerwerk Verwaltungs AG (Age 58, Pay $1.18M)
  • Mr. Rainer Klug, Exec. Board Member for Safety Division - Drägerwerk Verwaltungs AG (Age 53, Pay $1.09M)
  • Dr. Reiner Piske, Exec. Board Member for Sales & HR - Drägerwerk Verwaltungs AG (Age 51, Pay $1.17M)
  • Stephan Kruse, Head of Global Operations & Member of Supervisory Board (Age 51, Pay $40k)
  • Thomas Fischler, Head of Treasury & Investor Relations
  • Mr. Welf Böttcher, Head of Corp. Communications

Who are some of Drägerwerk AG & Co. KGaA's key competitors?

What other stocks do shareholders of Drägerwerk AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Drägerwerk AG & Co. KGaA investors own include ServiceNow (NOW), NVIDIA (NVDA), Skyworks Solutions (SWKS), Broadcom (AVGO), eBay (EBAY), Enterprise Products Partners (EPD), Tesla (TSLA), Verizon Communications (VZ), Advance Auto Parts (AAP) and Advanced Micro Devices (AMD).

What is Drägerwerk AG & Co. KGaA's stock symbol?

Drägerwerk AG & Co. KGaA trades on the ETR under the ticker symbol "DRW3."

What is Drägerwerk AG & Co. KGaA's stock price today?

One share of DRW3 stock can currently be purchased for approximately €74.95.

How much money does Drägerwerk AG & Co. KGaA make?

Drägerwerk AG & Co. KGaA has a market capitalization of $644.57 million and generates $3.41 billion in revenue each year.

How many employees does Drägerwerk AG & Co. KGaA have?

Drägerwerk AG & Co. KGaA employs 14,742 workers across the globe.

What is Drägerwerk AG & Co. KGaA's official website?

The official website for Drägerwerk AG & Co. KGaA is

Where are Drägerwerk AG & Co. KGaA's headquarters?

Drägerwerk AG & Co. KGaA is headquartered at Moislinger Allee 53-55, LUEBECK, 23558, Germany.

How can I contact Drägerwerk AG & Co. KGaA?

Drägerwerk AG & Co. KGaA's mailing address is Moislinger Allee 53-55, LUEBECK, 23558, Germany. The company can be reached via phone at +49-451-8820.

This page was last updated on 4/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.